Reflux nephropathy: Difference between revisions
No edit summary |
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +)) |
||
| Line 16: | Line 16: | ||
'''Associate Editor-In-Chief:''' {{CZ}} | '''Associate Editor-In-Chief:''' {{CZ}} | ||
==Overview== | ==Overview== | ||
| Line 34: | Line 34: | ||
{{Nephrology}} | {{Nephrology}} | ||
[[Category:Nephrology]] | [[Category:Nephrology]] | ||
Revision as of 15:36, 20 August 2012
| Reflux nephropathy | |
| ICD-9 | 593.73 |
|---|---|
| DiseasesDB | 11209 |
| MedlinePlus | 000459 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
Reflux nephropathy, RN is a term applied when small and scarred kidneys (chronic pyelonephritis, CPN) are associated with vesico-ureteric reflux (VUR). CPN being the commonest cause, there are other causes including analgesic nephropathy and obstructive injury. Scarring is essential in developing RN and occurs almost during the first five years of life. The end results of RN are hypertension, proteinuria, CRF and eventually ESRD, end stage renal disease.
Diagnosis
It is diagnosed by micturating cystography, scarring can of course be demonstrated by ultrasound or DMSA.
Incidence/prevalence
There is a genetic predisposition, first-degree relatives have a great increase in the chance of VUR.
The gene frequency is estimated to be 1:600. All children with UTI should be investigated for VUR.
Treatment
The aim of treatment is to reduce renal scarring. Those children with grade II or worse should receive low dose prophylactic antibiotics (Nitrofurantoin, trimethoprim, co-trimoxazole, cefalexin in those with CRF). Hypertension should be managed with ACE inhibitors or ARB's. Other treatment modalities also include surgery (endoscopic injection of collagen behind the intra-vesical ureter, ureteric re-implantation or lengthening of the submucosal ureteric tunnel) which has its protagonists.